# Management of Cardiovascular Disease in Kidney Disease (MaCK) Study

> **NCT03636152** · PHASE2 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 100 (actual)

## Conditions studied

- Chronic Kidney Disease
- Cardiovascular Disease
- Inflammation
- Atherosclerosis
- Aortic Stiffness

## Interventions

- **PROCEDURE:** MRI carotid
- **PROCEDURE:** APWV
- **DRUG:** Hydroxychloroquine
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT03636152
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-14
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03636152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03636152, "Management of Cardiovascular Disease in Kidney Disease (MaCK) Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03636152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*